Related Experiment Video
Updated: Jul 17, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Sarcoidosis in Iceland 1981-2003]
Sigrídur Olina Haraldsdottir1, Kristín Bára Jörundsdóttir, Fridrik Yngvason
1Lungnadeild Landspítala. sigrohar@landspitali.is
Laeknabladid
|February 6, 2007
Summary
This study found a low incidence of sarcoidosis in Iceland, with higher average age at diagnosis compared to other Nordic countries. Respiratory symptoms were most common, while severe manifestations were rare.
Area of Science:
- Pulmonary Medicine
- Immunology
- Epidemiology
Context:
- Sarcoidosis is a multisystem inflammatory disease characterized by non-caseating granulomas.
- Understanding the epidemiology and clinical presentation of sarcoidosis in diverse geographic locations is crucial for public health.
- Icelandic population data offers a unique perspective on sarcoidosis incidence and characteristics.
Purpose:
- To determine the incidence of sarcoidosis in Iceland.
- To describe the clinical manifestations of Icelandic sarcoidosis patients.
- To explore potential environmental influences on sarcoidosis in Iceland.
Summary:
- A 22-year study (1981-2003) identified 235 histologically confirmed sarcoidosis cases in Iceland.
- The annual incidence was 3.84/100,000, lower than other Nordic countries, with a noted increase in the latter half of the study period.
- Respiratory symptoms were predominant; ocular, erythema nodosum, and severe cardiovascular/neurological manifestations were infrequent. The mean age at diagnosis was higher than reported internationally.
Impact:
- Provides essential epidemiological data on sarcoidosis in Iceland.
- Highlights differences in sarcoidosis presentation and incidence compared to other populations.
- Suggests a need for improved environmental factor registration and clinical evaluation protocols for sarcoidosis.
Related Concept Videos
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...